These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20048464)

  • 1. Amoxapine-induced tardive dyskinesia.
    Singh GP
    Indian J Psychiatry; 2009; 51(4):327. PubMed ID: 20048464
    [No Abstract]   [Full Text] [Related]  

  • 2. Amoxapine-induced tardive dyskinesia.
    Tao GK; Harada DT; Kootsikas ME; Gordon MN; Brinkman JH
    Drug Intell Clin Pharm; 1985; 19(7-8):548-9. PubMed ID: 4028958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy.
    Thornton JE; Stahl SM
    Am J Psychiatry; 1984 May; 141(5):704-5. PubMed ID: 6711697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent tardive dyskinesia associated with amoxapine therapy--two case reports.
    Huang CC
    Hillside J Clin Psychiatry; 1986; 8(2):209-13. PubMed ID: 3557296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of tardive dyskinesia with amoxapine: case report.
    D'Mello DA; Nasrallah HA
    J Clin Psychiatry; 1986 Mar; 47(3):148. PubMed ID: 3949726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent tardive dyskinesia associated with amoxapine therapy.
    Huang CC
    Am J Psychiatry; 1986 Aug; 143(8):1069-70. PubMed ID: 3728738
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report of withdrawal dyskinesia associated with amoxapine.
    Weller RA; McKnelly WV
    Am J Psychiatry; 1983 Nov; 140(11):1515-6. PubMed ID: 6625005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of amoxapine-induced tardive dystonia successfully treated with a low dose anti-cholinergic agent].
    Hayashi Y; Ohyagi Y; Inoue I; Arakawa K; Taniwaki T; Nakagawa M; Kuwabara Y; Yamada T; Kira J
    Rinsho Shinkeigaku; 2000 Apr; 40(4):367-71. PubMed ID: 10967655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of withdrawal dyskinesia associated with amoxapine.
    Lesser I
    Am J Psychiatry; 1983 Oct; 140(10):1358-9. PubMed ID: 6624971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report.
    Haile K; Umer H
    SAGE Open Med Case Rep; 2019; 7():2050313X19833254. PubMed ID: 30834119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone and olanzapine induced tardive dyskinesia : a critical review of reported cases.
    Singh GP
    Indian J Psychiatry; 2004 Oct; 46(4):319-23. PubMed ID: 21206790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H; Qin H; Chen S; Guan M
    Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone induced tardive dyskinesia - a case report.
    Vasudevan OV; Pinto DA; Gopinath PS
    Indian J Psychiatry; 2002 Oct; 44(4):384-6. PubMed ID: 21206608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB; Kuczenski R; Niculescu AB
    CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.